Exagen (XGN) Change in Receivables (2018 - 2026)
Exagen filings provide 9 years of Change in Receivables readings, the most recent being $4.9 million for Q1 2026.
- On a quarterly basis, Change in Receivables fell 28.65% to $4.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.0 million, a 72.69% decrease, with the full-year FY2025 number at $3.0 million, up 135.2% from a year prior.
- Change in Receivables hit $4.9 million in Q1 2026 for Exagen, up from -$237000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $6.9 million in Q2 2023 to a low of -$10.5 million in Q4 2023.
- Median Change in Receivables over the past 5 years was $802000.0 (2024), compared with a mean of $359941.2.
- Biggest five-year swings in Change in Receivables: plummeted 1127.48% in 2022 and later soared 415.66% in 2023.
- Exagen's Change in Receivables stood at -$4.6 million in 2022, then tumbled by 130.01% to -$10.5 million in 2023, then skyrocketed by 85.21% to -$1.6 million in 2024, then skyrocketed by 84.73% to -$237000.0 in 2025, then soared by 2175.11% to $4.9 million in 2026.
- The last three reported values for Change in Receivables were $4.9 million (Q1 2026), -$237000.0 (Q4 2025), and -$3.6 million (Q3 2025) per Business Quant data.